Cargando…

Reported rates of CVST due to COVID-19 vaccination rose after publicising these ADRs

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795342/ http://dx.doi.org/10.1007/s40278-022-09262-6

Ejemplares similares

Quality of ADR reporting evaluated for remdesivir trials of COVID-19
Publicado: (2020)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Sex differences in ADR reports for drugs used to treat COVID-19
Publicado: (2020)

High incidence of ADRs in COVID-19 patients in China
Publicado: (2020)

Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19
por: Mazzeo, Anna Teresa, et al.
Publicado: (2021)

Increase in thromboembolic ADRs from oral contraceptives during COVID-19 pandemic in Spain
Publicado: (2022)

Endovascular clot retrieval in extensive cerebral venous sinus thrombosis (CVST): a videographic report
por: Abid, Muhammad Bilal, et al.
Publicado: (2017)

COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and Cerebral Venous Sinus Thrombosis (CVST)- Lessons for India
por: Khan, Erum, et al.
Publicado: (2022)

Norethisterone enanthate-induced cerebral venous sinus thrombosis (CVST)
por: Bahall, Mandreker, et al.
Publicado: (2017)

Expected rates of adverse events after COVID-19 vaccination in USA
Publicado: (2022)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

Gynecomastia: An ADR due to drug interaction
por: Aiman, Umme, et al.
Publicado: (2009)

Clinical profile and risk factors of cerebral venous sinus thrombosis (CVST) in Sudan: A multicenter cross-sectional study
por: Ibrahim, Etedal Ahmed A., et al.
Publicado: (2022)

Predictive Value of Combination of D-dimer and Fibrinogen in Diagnosing Acute CVST
por: Pathak, Abhishek, et al.
Publicado: (2021)

MHRA COVID-19 website for reporting ADRs and incidents
Publicado: (2020)

Coronavirus disease 19 (COVID‐19) and Cerebral venous sinus thrombosis (CVST): A case series and review of the literature
por: Kallel, Nesrine, et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous sinus thrombosis (CVST): a case report from Malaysia
por: Liam, Christopher Chin Keong, et al.
Publicado: (2022)

Rare reports of rheumatic disorder flares after COVID-19 vaccination
Publicado: (2022)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

Network Characteristic Analysis of ADR-related Proteins and Identification of ADR-ADR Associations
por: Chen, Xiujie, et al.
Publicado: (2013)

ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST)
por: Suresh, Preethi, et al.
Publicado: (2021)

Thrombocytopenia and thromboembolism after COVID-19 vaccination
Publicado: (2021)

Universal COVID-19 vaccination cost saving unless anaphylaxis rate high
Publicado: (2021)

Systemic AEs common after COVID-19 vaccination
Publicado: (2022)

Acute neurological AEs after COVID-19 vaccination
Publicado: (2022)

Epilepsia Partialis Continua (EPC) as an Uncommon Initial Presentation of Cerebral Venous Sinus Thrombosis (CVST)
por: Chee, Yong Chuan, et al.
Publicado: (2022)

Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or infection: A national cohort study using linked electronic health records
por: Ohaeri, Columbus, et al.
Publicado: (2022)

No increased risk for venous thromboembolism after COVID-19 vaccination
Publicado: (2022)

Cerebral venous sinus thrombosis after COVID-19 vaccination
Publicado: (2021)

Myocarditis rare after COVID-19 mRNA vaccination
Publicado: (2021)

COVID-19 vaccine adverse events reported via app
Publicado: (2021)

Small change in menstrual cycle length after COVID-19 vaccination
Publicado: (2022)

Cerebral vein thrombosis after four COVID-19 vaccines in Europe
Publicado: (2021)

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021)

Focus on pharmacogenomics, phytonutrient–drug interactions and COVID-19 vaccines: Perspectives on ADRs, ADEs, and SEDs
por: Ray, Sidhartha D., et al.
Publicado: (2022)

Focus on pharmacogenomics, phytonutrient-drug interactions and COVID-19 vaccines: Perspectives on ADRs, ADEs, and SEDs
por: Ray, Sidhartha D., et al.
Publicado: (2021)

Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
Publicado: (2022)

No safety signal after COVID-19 vaccination for immune-mediated neurological events
Publicado: (2022)

FAPIC score predicts mortality after COVID-19 vaccine-related TTS
Publicado: (2021)

The Adolescent Depression Rating Scale (ADRS): a validation study
por: Revah-Levy, Anne, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ljpn154if1k04p8q8d84a910tf